Sonrotoclax trial in high-risk myelodysplastic syndromes
NCT07885397 tests sonrotoclax in high-risk MDS; ChEMBL potency and 35 ClinicalTrials.gov studies show what is already known about the drug and its target.
BioQ Blog
Every BioQ post about BCL2 inhibitor: real search results, sources and the query to repeat it.
NCT07885397 tests sonrotoclax in high-risk MDS; ChEMBL potency and 35 ClinicalTrials.gov studies show what is already known about the drug and its target.